Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
24.80
+0.56 (2.31%)
At close: Mar 9, 2026, 4:00 PM EDT
24.79
-0.01 (-0.04%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Catalyst Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 214.33 | 163.89 | 71.41 | 83.08 | 39.48 | |
| Depreciation & Amortization | 37.87 | 37.77 | 32.88 | 1.24 | 0.19 | |
| Asset Writedown & Restructuring Costs | - | - | 81.51 | - | - | |
| Loss (Gain) From Sale of Investments | -0.97 | -5.08 | -3.02 | 0.76 | - | |
| Stock-Based Compensation | 24.78 | 22.25 | 14.25 | 7.91 | 6.07 | |
| Other Operating Activities | -6.44 | -9.95 | -16.11 | 9.33 | 9.6 | |
| Change in Accounts Receivable | -61 | -11.96 | -43.08 | -3.82 | -0.63 | |
| Change in Inventory | -18.09 | -3.9 | -4.74 | 1.07 | -3.22 | |
| Change in Accounts Payable | -5.39 | 1.8 | 10.82 | 1.21 | -1.49 | |
| Change in Other Net Operating Assets | 23.59 | 44.98 | -0.33 | 15.28 | 10.36 | |
| Operating Cash Flow | 208.67 | 239.81 | 143.6 | 116.05 | 60.37 | |
| Operating Cash Flow Growth | -12.98% | 67.00% | 23.74% | 92.22% | 34.06% | |
| Capital Expenditures | -0.06 | -0.56 | -198.52 | -10.03 | -1.02 | |
| Sale (Purchase) of Intangibles | - | - | -81.51 | - | - | |
| Investment in Securities | - | - | -13.47 | 19.24 | -10 | |
| Investing Cash Flow | -0.06 | -0.56 | -293.5 | 9.21 | -11.02 | |
| Issuance of Common Stock | 14.67 | 154.52 | 2.79 | 9.57 | 4.1 | |
| Repurchase of Common Stock | -27.07 | -0.67 | -0.98 | -7.14 | -12.24 | |
| Other Financing Activities | -4.59 | -13.18 | -12.67 | -0.74 | - | |
| Financing Cash Flow | -16.99 | 140.67 | -10.86 | 1.69 | -8.14 | |
| Net Cash Flow | 191.62 | 379.92 | -160.76 | 126.95 | 41.21 | |
| Free Cash Flow | 208.61 | 239.25 | -54.92 | 106.02 | 59.35 | |
| Free Cash Flow Growth | -12.81% | - | - | 78.63% | 31.82% | |
| Free Cash Flow Margin | 35.42% | 48.66% | -13.79% | 49.49% | 42.14% | |
| Free Cash Flow Per Share | 1.64 | 1.92 | -0.48 | 0.95 | 0.55 | |
| Cash Interest Paid | 0.47 | 1.4 | 0.71 | - | - | |
| Cash Income Tax Paid | 71.99 | 68.45 | 50.46 | 7.67 | 3 | |
| Levered Free Cash Flow | 171.34 | 201.64 | -219.49 | 89.69 | 42.14 | |
| Unlevered Free Cash Flow | 171.34 | 201.64 | -219.49 | 89.69 | 42.14 | |
| Change in Working Capital | -60.9 | 30.91 | -37.32 | 13.73 | 5.02 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.